Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of sacubitril/valsartan 200 mg tablets vs Entresto 200 mg in healthy Thai volunteers under fasting
TCTR20250505004Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sacubitril + valsartan (2 arms), sponsored by Bio-innova. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
Beyond the preview
Go deeper on TCTR20250505004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250505004.